At the completion of this CME activity, subscribers should be able to:
- Differentiate benign breast disease and atypical proliferative lesions.
- Discuss liver biopsies in the post-HCV era.
- Achieve a better understanding of HER in GI malignancies and comparisons to breast.
- Prepare for colon cancer and universal screening for Lynch syndrome.
- Identify conditions to consider before surgical pathology subspecialty sign-out.
- Discuss breast cancer predictive factor testing (ER, PR & HER2).
- Analyze myxoid soft tissue tumors and peripheral nerve sheath tumors.
- Identify key features of genomic testing in breast cancer diagnosis and treatment planning.
- Describe sclerosing lesions of the breast.
- Discuss the utility of cytogenetic and FISH studies in workup of adipocytic lesions.
- Review differential diagnoses and pitfalls in fatty tumors.
- Review the appropriate use (and potential pitfalls) of MDM2 FISH studies in the work-up of a spindle cell malignancy in the retroperitoneum.
- Discuss bone-forming and cartilage-forming soft tissue tumors, as well as sarcomas that may occasionally produce matrix.
- Discuss the differential diagnosis of a spindle cell sarcoma with herringbone/fascicular growth.
- Discuss peripheral nerve sheath tumors, fibrohistiocytic neoplasms and vascular lesions.
- Review new entities such as soft tissue angiofibroma and biphenotypic sinonasal sarcoma.
- Review entities such as fibroepithelial stromal polyp, cellular angiofibroma, mammary-type myofibroblastoma, angiomyofibroblastoma and aggressive angiomyxoma, as well as their mimics.
No special educational preparation is required for this CME activity